Abstract
OBJECTIVE--To assess the effect of long term antihypertensive treatment on prognosis in diabetic nephropathy. DESIGN--Prospective study of all insulin dependent diabetic patients aged under 50 with onset of diabetes before the age of 31 who developed diabetic nephropathy between 1974 and 1978 at Steno Memorial Hospital. SETTING--Outpatient diabetic clinic in tertiary referral centre. PATIENTS--Forty five patients (20 women) with a mean age of 30 (SD 7) years and a mean duration of diabetes of 18 (7) years at onset of persistent proteinuria were followed until death or for at least 10 years. INTERVENTIONS--Antihypertensive treatment was started a median of three (0-13) years after onset of nephropathy. Four patients (9%) received no treatment, and 9 (20%), 13 (29%), and 19 (42%) were treated with one, two, or three drugs, respectively. The median follow up was 12 (4-15) years. MAIN OUTCOME MEASURES--Arterial blood pressure and death. RESULTS--Mean blood pressure at start of antihypertensive treatment was 148/95 (15/50) mm Hg. Systolic blood pressure remained almost unchanged (slope -0.01 (95% confidence interval -0.39 to 0.37) mm Hg a year) while diastolic blood pressure decreased significantly (0.87 (0.65 to 1.10) mm Hg a year) during antihypertensive treatment. The cumulative death rate was 18% (8 to 32%) 10 years after onset of nephropathy, in contrast to previous reports of 50% to 77% 10 years after onset of nephropathy. As in previous studies, uraemia was the main cause of death (9 patients; 64%). CONCLUSIONS--The prognosis of diabetic nephropathy has improved during the past decade largely because of effective antihypertensive treatment.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andersen A. R., Christiansen J. S., Andersen J. K., Kreiner S., Deckert T. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia. 1983 Dec;25(6):496–501. doi: 10.1007/BF00284458. [DOI] [PubMed] [Google Scholar]
- Berglund J., Lins L. E., Lins P. E. Metabolic and blood pressure monitoring in diabetic renal failure. Acta Med Scand. 1985;218(4):401–408. doi: 10.1111/j.0954-6820.1985.tb08865.x. [DOI] [PubMed] [Google Scholar]
- Björck S., Nyberg G., Mulec H., Granerus G., Herlitz H., Aurell M. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J (Clin Res Ed) 1986 Aug 23;293(6545):471–474. doi: 10.1136/bmj.293.6545.471. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Borch-Johnsen K., Andersen P. K., Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1985 Aug;28(8):590–596. doi: 10.1007/BF00281993. [DOI] [PubMed] [Google Scholar]
- Borch-Johnsen K., Kreiner S. Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) 1987 Jun 27;294(6588):1651–1654. doi: 10.1136/bmj.294.6588.1651. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brenner B. M. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int. 1983 Apr;23(4):647–655. doi: 10.1038/ki.1983.72. [DOI] [PubMed] [Google Scholar]
- Cohen D., Dodds R., Viberti G. Effect of protein restriction in insulin dependent diabetics at risk of nephropathy. Br Med J (Clin Res Ed) 1987 Mar 28;294(6575):795–798. doi: 10.1136/bmj.294.6575.795. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eggers P. W. Effect of transplantation on the Medicare end-stage renal disease program. N Engl J Med. 1988 Jan 28;318(4):223–229. doi: 10.1056/NEJM198801283180406. [DOI] [PubMed] [Google Scholar]
- Hasslacher C., Stech W., Wahl P., Ritz E. Blood pressure and metabolic control as risk factors for nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia. 1985 Jan;28(1):6–11. doi: 10.1007/BF00276992. [DOI] [PubMed] [Google Scholar]
- Knowles H. C., Jr Long-term juvenile diabetes treated with unmeasured diet. Trans Assoc Am Physicians. 1971;84:95–101. [PubMed] [Google Scholar]
- Krolewski A. S., Warram J. H., Christlieb A. R., Busick E. J., Kahn C. R. The changing natural history of nephropathy in type I diabetes. Am J Med. 1985 May;78(5):785–794. doi: 10.1016/0002-9343(85)90284-0. [DOI] [PubMed] [Google Scholar]
- Mauer S. M., Steffes M. W., Brown D. M. The kidney in diabetes. Am J Med. 1981 Mar;70(3):603–612. doi: 10.1016/0002-9343(81)90582-9. [DOI] [PubMed] [Google Scholar]
- Mogensen C. E. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J (Clin Res Ed) 1982 Sep 11;285(6343):685–688. doi: 10.1136/bmj.285.6343.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mortensen H. B. Quantitative determination of hemoglobin A1c by thin-layer isoelectric focusing. J Chromatogr. 1980 Jun 13;182(3-4):325–333. doi: 10.1016/s0378-4347(00)81481-4. [DOI] [PubMed] [Google Scholar]
- Nyberg G., Blohmé G., Nordén G. Impact of metabolic control in progression of clinical diabetic nephropathy. Diabetologia. 1987 Feb;30(2):82–86. doi: 10.1007/BF00274576. [DOI] [PubMed] [Google Scholar]
- Nyberg G., Nordén G., Attman P. O., Aurell M., Uddebom G., Lenner R. A., Isaksson B. Diabetic nephropathy: is dietary protein harmful? J Diabet Complications. 1987 Apr-Jun;1(2):37–40. doi: 10.1016/s0891-6632(87)80077-6. [DOI] [PubMed] [Google Scholar]
- Parving H. H., Andersen A. R., Smidt U. M., Hommel E., Mathiesen E. R., Svendsen P. A. Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J (Clin Res Ed) 1987 Jun 6;294(6585):1443–1447. doi: 10.1136/bmj.294.6585.1443. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Parving H. H., Andersen A. R., Smidt U. M., Oxenbøll B., Edsberg B., Christiansen J. S. Diabetic nephropathy and arterial hypertension. Diabetologia. 1983 Jan;24(1):10–12. doi: 10.1007/BF00275939. [DOI] [PubMed] [Google Scholar]
- Parving H. H., Andersen A. R., Smidt U. M., Svendsen P. A. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet. 1983 May 28;1(8335):1175–1179. doi: 10.1016/s0140-6736(83)92462-5. [DOI] [PubMed] [Google Scholar]
- Parving H. H., Hommel E., Mathiesen E., Skøtt P., Edsberg B., Bahnsen M., Lauritzen M., Hougaard P., Lauritzen E. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J (Clin Res Ed) 1988 Jan 16;296(6616):156–160. doi: 10.1136/bmj.296.6616.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Parving H. H., Hommel E., Smidt U. M. Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ. 1988 Oct 29;297(6656):1086–1091. doi: 10.1136/bmj.297.6656.1086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Parving H. H., Smidt U. M., Friisberg B., Bonnevie-Nielsen V., Andersen A. R. A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia. 1981 Apr;20(4):457–461. doi: 10.1007/BF00253407. [DOI] [PubMed] [Google Scholar]
- Viberti G. C., Bilous R. W., Mackintosh D., Bending J. J., Keen H. Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes. Br Med J (Clin Res Ed) 1983 Feb 19;286(6365):598–602. doi: 10.1136/bmj.286.6365.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Viberti G. C., Bilous R. W., Mackintosh D., Keen H. Monitoring glomerular function in diabetic nephropathy. A prospective study. Am J Med. 1983 Feb;74(2):256–264. doi: 10.1016/0002-9343(83)90624-1. [DOI] [PubMed] [Google Scholar]
- Viberti G., Keen H., Dodds R., Bending J. J. Metabolic control and progression of diabetic nephropathy. Diabetologia. 1987 Jul;30(7):481–482. doi: 10.1007/BF00279616. [DOI] [PubMed] [Google Scholar]